about
Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencingPhosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibitionGene name errors are widespread in the scientific literatureApplicability of histone deacetylase inhibition for the treatment of spinal muscular atrophyEtiology matters - Genomic DNA Methylation Patterns in Three Rat Models of Acquired Epilepsy.The neuronal noradrenaline transporter, anxiety and cardiovascular diseaseRole of histone acetylation in the stimulatory effect of valproic acid on vascular endothelial tissue-type plasminogen activator expressionRapid development of non-alcoholic steatohepatitis in Psammomys obesus (Israeli sand rat)Ubiquitin-specific protease 2-69 in macrophages potentially modulates metainflammationThe primary microRNA-208b interacts with Polycomb-group protein, Ezh2, to regulate gene expression in the heartGenetic and epigenetic events in diabetic wound healing.Contraction-induced interleukin-6 gene transcription in skeletal muscle is regulated by c-Jun terminal kinase/activator protein-1Deep sequencing reveals increased DNA methylation in chronic rat epilepsy.Non-referenced genome assembly from epigenomic short-read dataNET silencing by let-7i in postural tachycardia syndrome.Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain.Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.Vascular histone deacetylation by pharmacological HDAC inhibition.Investigation into the biological properties of the olive polyphenol, hydroxytyrosol: mechanistic insights by genome-wide mRNA-Seq analysis.Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation.Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes.Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance.Methylation of the SLC6a2 gene promoter in major depression and panic disorderDevelopment of novel activin-targeted therapeutics.Remodeling is at the heart of chromatin: the heartaches of chromatin.Evaluation of the spatial distribution of gammaH2AX following ionizing radiation.Quantitation of gammaH2AX foci in tissue samples.Quantification of gammaH2AX foci in response to ionising radiation.Clonogenic assay: adherent cellsGenetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetes.Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells.The rise of DNA methylation and the importance of chromatin on multidrug resistance in cancer.DNMT cooperativity--the developing links between methylation, chromatin structure and cancer.The rise and fall of genomic methylation in cancer.Epigenetic changes activate widespread signals in response to double-strand breaks.Microparticles: major transport vehicles for distinct microRNAs in circulation.Understanding the consequences of epigenetic mechanisms and its effects on transcription in health and disease.MDR1, chemotherapy and chromatin remodeling.Double-strand breaks: signaling pathways and repair mechanisms.
P50
Q24294291-77B8AA22-6CE2-4DFF-846C-27E9F2C14AF0Q24337301-74334438-60FD-4E49-9833-C1614C3BC24DQ24655533-2E1844C7-3D10-4DB0-8A2C-8D7C92CF228EQ26699971-C7D1DD62-EA44-4034-9DA4-95893D5F91BAQ26864605-CC19D5B0-EAB7-4C94-BAA8-D27671ADB6CDQ27316575-67537E7D-19E6-4735-84E1-F1BFFDBC64DDQ28247061-2035E23D-ACC6-4A19-B97F-AE016788AE62Q28480965-78439FC0-657E-4E0D-AB59-0BC683FF7BB3Q28541267-BB6B28DE-CC48-4693-8DC1-ACE7082D4C52Q28586191-3643F3C3-E6A1-4F7B-BDA4-38E26C8FC26BQ28586308-E552E455-B61D-4CFB-A993-9D521B44AA95Q30397422-F670CF95-AB6F-4C2C-9527-F9602CEDE736Q30512877-9959A9A5-AE2F-42D3-BE57-28583DBC7D36Q30557209-35085C92-A39E-4B56-9354-A675A70BC1B1Q30872605-4F03739F-F83B-4372-BD07-194069A9C971Q33168474-B77F45EB-CD5C-4332-9435-4DC72F717FE6Q33564995-7B172C0C-B84D-4C63-AD8E-09E1A5223AF2Q33660629-24B870DE-27F3-4CB5-9EC0-5968506E4543Q33994818-50C30886-9FFB-4C62-8FC7-DAD2BCD3BDCBQ34033276-626E7FD5-0039-4E5D-8040-445FB2BFD5FBQ34324051-96D72645-48E3-4912-A6C4-FFA79BEAC655Q34361211-1B40DE14-DF65-4259-85F1-8EF81F7F0C41Q34480035-1AC5E406-851D-47BA-8D52-E1BFC97239DAQ35061589-5350B247-96F8-4FD0-81DA-140B80D34EEEQ35153096-CC14C23D-6852-414B-B7AA-635C12C6460AQ35159041-87FBF36E-E57C-49AF-8491-9D56C4BAA2C1Q35164192-86D9F282-8D65-4427-8E5B-0E4A0085C8EAQ35164325-E9D1EE66-5CE8-46E2-A5F2-691090F0A878Q35187338-3573363A-CDDD-48E1-9EB2-404324E4AA3AQ35394906-1B27F35F-97E8-435E-85C9-AE50BFDED98CQ35405420-8F7AEE9F-CD6E-405F-B207-67C6E200BF13Q35451716-31611438-AE01-4A46-B590-8CC2C82A0F1FQ35563862-A9AB959D-061D-4D21-90E8-18FB15944203Q35568157-2015CC20-CCBB-4D6D-A1BB-279E1056AA6FQ35589077-CFA5EFDD-95EE-4652-90FF-78DA80C0677AQ35770116-DD20227E-B5CB-4B73-9134-C78C72F56E39Q35792749-629E040E-F1AB-45B8-AE39-1F96FD6EE077Q35869814-463623AB-8C12-437D-81C7-0F470F2F2998Q35869829-8070B385-52BE-4F11-B9E6-813EDB3B938CQ35874905-16DB942F-794D-429F-BDD5-7E181D331412
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Assam El-osta
@ast
Assam El-osta
@en
Assam El-osta
@es
Assam El-osta
@nl
type
label
Assam El-osta
@ast
Assam El-osta
@en
Assam El-osta
@es
Assam El-osta
@nl
altLabel
Sam El-Osta
@en
prefLabel
Assam El-osta
@ast
Assam El-osta
@en
Assam El-osta
@es
Assam El-osta
@nl
P106
P1153
8966609000
P31
P496
0000-0001-7968-7375